Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer—the more specific, the better?

Antzeko izenburuak

• Adjuvant Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer
  nork: Lourdes, Laura S., et al.
  Argitaratua: (2015)
• Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready?
  nork: Tabbò, Fabrizio, et al.
  Argitaratua: (2020)
• Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer
  nork: Zhai, Haoran, et al.
  Argitaratua: (2015)
• The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
  nork: Chang, Shih-Chieh, et al.
  Argitaratua: (2011)
• Cutaneous adverse reactions specific to epidermal growth factor receptor inhibitors
  nork: Lupu, I, et al.
  Argitaratua: (2015)